1
|
Sperber AD, Bangdiwala SI, Drossman DA,
Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X,
Fukudo S, et al: Worldwide prevalence and burden of functional
gastrointestinal disorders, results of rome foundation global
study. Gastroenterology. 160:99–114.e3. 2021.PubMed/NCBI View Article : Google Scholar
|
2
|
Higgins PD and Johanson JF: Epidemiology
of constipation in North America: A systematic review. Am J
Gastroenterol. 99:750–759. 2004.PubMed/NCBI View Article : Google Scholar
|
3
|
Tamura A, Tomita T, Oshima T, Toyoshima F,
Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Ikehara H, et al:
Prevalence and self-recognition of chronic constipation: Results of
an internet survey. J Neurogastroenterol Motil. 22:677–685.
2016.PubMed/NCBI View
Article : Google Scholar
|
4
|
Wald A, Scarpignato C, Kamm MA,
Mueller-Lissner S, Helfrich I, Schuijt C, Bubeck J, Limoni C and
Petrini O: The burden of constipation on quality of life: Results
of a multinational survey. Aliment Pharmacol Ther. 26:227–236.
2007.PubMed/NCBI View Article : Google Scholar
|
5
|
Tanabe A, Adachi K, Yamaguchi Y, Izawa S,
Yamamoto S, Hijikata Y, Ebi M, Funaki Y, Ogasawara N, Goto C, et
al: Gut environment and dietary habits in healthy Japanese adults
and their association with bowel movement. Digestion. 101:706–716.
2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Canavan C, West J and Card T: Review
article: The economic impact of the irritable bowel syndrome.
Aliment Pharmacol Ther. 40:1023–1034. 2014.PubMed/NCBI View Article : Google Scholar
|
7
|
Appleby RN and Walters JR: The role of
bile acids in functional GI disorders. Neurogastroenterol Motil.
26:1057–1069. 2014.PubMed/NCBI View Article : Google Scholar
|
8
|
Nakajima A, Seki M and Taniguchi S:
Determining an optimal clinical dose of elobixibat, a novel
inhibitor of the ileal bile acid transporter, in Japanese patients
with chronic constipation: A phase II, multicenter, double-blind,
placebo-controlled randomized clinical trial. J Gastroenterol.
53:525–534. 2018.PubMed/NCBI View Article : Google Scholar
|
9
|
Nakajima A, Seki M, Taniguchi S, Ohta A,
Gillberg PG, Mattsson JP and Camilleri M: Safety and efficacy of
elobixibat for chronic constipation: results from a randomised,
double-blind, placebo-controlled, phase-3 trial and an open-label,
single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 3:537–547.
2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Beeckmans D, Farré R, Riethorst D, Keita
ÅV, Augustijns P, Söderholm JD, Vanuytsel T, Vanheel H and Tack J:
Relationship between bile salts, bacterial translocation, and
duodenal mucosal integrity in functional dyspepsia.
Neurogastroenterol Motil. 32(e13788)2022.PubMed/NCBI View Article : Google Scholar
|
11
|
Wauters L, Ceulemans M, Lambaerts M,
Accarie A, Toth J, Mols R, Augustijns P, Tack J and Vanuytsel T:
Association between duodenal bile salts and gastric emptying in
patients with functional dyspepsia. Gut. 70:2208–2210.
2021.PubMed/NCBI View Article : Google Scholar
|
12
|
Choi HJ, Moon JH and Lee YN: . Advanced
imaging technology in biliary tract diseases:Narrow-band imaging of
the bile duct. Clin Endosc. 48:498–502. 2015.PubMed/NCBI View Article : Google Scholar
|
13
|
Moon JH, Terheggen G, Choi HJ and Neuhaus
H: Peroral cholangioscopy: Diagnostic and therapeutic applications.
Gastroenterology. 144:276–282. 2013.PubMed/NCBI View Article : Google Scholar
|
14
|
Itoi T, Sofuni A, Itokawa F, Tsuchiya T,
Kurihara T, Ishii K, Tsuji S, Moriyasu F and Gotoda T: Peroral
cholangioscopic diagnosis of biliary-tract diseases by using
narrow-band imaging (with videos). Gastrointest Endosc. 66:730–736.
2007.PubMed/NCBI View Article : Google Scholar
|
15
|
Armstrong D, Bennett JR, Blum AL, Dent J,
De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE,
Spechler SJ, et al: The endoscopic assessment of esophagitis: A
progress report on observer agreement. Gastroenterology. 111:85–92.
1996.PubMed/NCBI View Article : Google Scholar
|
16
|
Hongo M: Minimal changes in reflux
esophagitis: Red ones and white ones. J Gastroenterol. 41:95–99.
2006.PubMed/NCBI View Article : Google Scholar
|
17
|
Sharma P, Dent J, Armstrong D, Bergman JJ,
Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat
GN and Vieth M: The development and validation of an endoscopic
grading system for Barrett's esophagus: the Prague C & M
criteria. Gastroenterology. 131:1392–1399. 2006.PubMed/NCBI View Article : Google Scholar
|
18
|
Kimura K and Takemoto T: An endoscopic
recognition of the atrophic border and its significance in chronic
gastritis. Endoscopy. 1:87–97. 1969.
|
19
|
Agachan F, Chen T, Pfeifer J, Reissman P
and Wexner SD: A constipation scoring system to simplify evaluation
and management of constipated patients. Dis Colon Rectum.
39:681–685. 1996.PubMed/NCBI View Article : Google Scholar
|
20
|
Lewis SJ and Heaton KW: Stool form scale
as a useful guide to intestinal transit time. Scand J
Gastroenterol. 32:920–924. 1997.PubMed/NCBI View Article : Google Scholar
|
21
|
Chiang JY: Bile acid metabolism and
signaling. Compr Physiol. 3:1191–1212. 2013.PubMed/NCBI View Article : Google Scholar
|
22
|
Chiang JYL and Ferrell JM: Bile acid
metabolism in liver pathobiology. Gene Expr. 18:71–87.
2018.PubMed/NCBI View Article : Google Scholar
|
23
|
Di Ciaula A, Garruti G, Lunardi Baccetto
R, Molina-Molina E, Bonfrate L, Wang DQ and Portincasa P: Bile acid
physiology. Ann Hepatol. 16 (Suppl 1: S3-S105):S4–S14.
2017.PubMed/NCBI View Article : Google Scholar
|
24
|
Bampton PA, Dinning PG, Kennedy ML,
Lubowski DZ and Cook IJ: The proximal colonic motor response to
rectal mechanical and chemical stimulation. Am J Physiol
Gastrointest Liver Physiol. 282:G443–G449. 2002.PubMed/NCBI View Article : Google Scholar
|
25
|
Hofmann AF: The continuing importance of
bile acids in liver and intestinal disease. Arch Intern Med.
159:2647–2658. 1999.PubMed/NCBI View Article : Google Scholar
|
26
|
Edwards CA, Brown S, Baxter AJ, Bannister
JJ and Read NW: Effect of bile acid on anorectal function in man.
Gut. 30:383–386. 1989.PubMed/NCBI View Article : Google Scholar
|
27
|
Shin A, Camilleri M, Vijayvargiya P,
Busciglio I, Burton D, Ryks M, Rhoten D, Lueke A, Saenger A,
Girtman A and Zinsmeister AR: Bowel functions, fecal unconjugated
primary and secondary bile acids, and colonic transit in patients
with irritable bowel syndrome. Clin Gastroenterol Hepatol.
11:1270–1275.e1. 2013.PubMed/NCBI View Article : Google Scholar
|
28
|
Rao AS, Wong BS, Camilleri M,
Odunsi-Shiyanbade ST, McKinzie S, Ryks M, Burton D, Carlson P,
Lamsam J, Singh R and Zinsmeister AR: Gastroenterology.
139:1549–1558. 2010.
|
29
|
Camilleri M: Bile acid diarrhea:
Prevalence, pathogenesis, and therapy. Gut Liver. 9:332–339.
2015.PubMed/NCBI View
Article : Google Scholar
|
30
|
Yueh TP, Chen FY, Lin TE and Chuang MT:
Diarrhea after laparoscopic cholecystectomy: Associated factors and
predictors. Asian J Surg. 37:171–177. 2014.PubMed/NCBI View Article : Google Scholar
|
31
|
Hutcheon DF, Bayless TM and Gadacz TR:
Postcholecystectomy diarrhea. JAMA. 241:823–824. 1979.PubMed/NCBI
|
32
|
Fisher M, Spilias DC and Tong LK:
Diarrhoea after laparoscopic cholecystectomy: Incidence and main
determinants. ANZ J Surg. 78:482–486. 2008.PubMed/NCBI View Article : Google Scholar
|
33
|
Middelfart HV, Kristensen JU, Laursen CN,
Qvist N, Højgaard L, Funch-Jensen P and Kehlet H: Pain and
dyspepsia after elective and acute cholecystectomy. Scand J
Gastroenterol. 33:10–14. 1998.PubMed/NCBI View Article : Google Scholar
|
34
|
Lublin M, Crawford DL, Hiatt JR and
Phillips EH: Symptoms before and after laparoscopic cholecystectomy
for gallstones. Am Surg. 70:863–866. 2004.PubMed/NCBI
|
35
|
Weinert CR, Arnett D, Jacobs D Jr and Kane
RL: Relationship between persistence of abdominal symptoms and
successful outcome after cholecystectomy. Arch Intern Med.
160:989–995. 2000.PubMed/NCBI View Article : Google Scholar
|
36
|
Niranjan B, Chumber S and Kriplani AK:
Symptomatic outcome after laparoscopic cholecystectomy. Trop
Gastroenterol. 21:144–148. 2000.PubMed/NCBI
|
37
|
Lamberts MP, Lugtenberg M, Rovers MM,
Roukema AJ, Drenth JP, Westert GP and van Laarhoven CJ: Persistent
and de novo symptoms after cholecystectomy: A systematic review of
cholecystectomy effectiveness. Surg Endosc. 27:709–718.
2013.PubMed/NCBI View Article : Google Scholar
|
38
|
Sciarretta G, Furno A, Mazzoni M and
Malaguti P: Post-cholecystectomy diarrhea: evidence of bile acid
malabsorption assessed by SeHCAT test. Am J Gastroenterol.
87:1852–1854. 1992.PubMed/NCBI
|
39
|
Mearin F, De Ribot X, Balboa A, Antolín M,
Varas MJ and Malagelada JR: Duodenogastric bile reflux and
gastrointestinal motility in pathogenesis of functional dyspepsia.
Role of cholecystectomy. Dig Dis Sci. 40:1703–1709. 1995.PubMed/NCBI View Article : Google Scholar
|
40
|
Monaco L, Brillantino A, Torelli F,
Schettino M, Izzo G, Cosenza A and Di Martino N: Prevalence of bile
reflux in gastroesophageal reflux disease patients not responsive
to proton pump inhibitors. World J Gastroenterol. 15:334–338.
2009.PubMed/NCBI View Article : Google Scholar
|
41
|
Bollschweiler E, Wolfgarten E, Pütz B,
Gutschow C and Hölscher AH: Bile reflux into the stomach and the
esophagus for volunteers older than 40 years. Digestion. 71:65–71.
2005.PubMed/NCBI View Article : Google Scholar
|
42
|
McCabe ME IV and Dilly CK: New causes for
the old problem of bile reflux gastritis. Clin Gastroenterol
Hepatol. 16:1389–1392. 2018.PubMed/NCBI View Article : Google Scholar
|